López-Dionicio YI, Ortiz-Flores MÁ, Hidalgo I, Ortiz-Vilchis P, Guevara G, Nájera N, Ceballos G, Meaney E

Idioma: Inglés [English version]
Referencias bibliográficas: 146
Paginas: 58-69
Archivo PDF: 502.39 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Campos-Nonato I, Galván-Valencia O, Hernández-Barrera L, Oviedo-Solís C, Barquera S. Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la Ensanut 2022. Salud Publica Mex. 2023; 65: s238-s247.

2. Meaney E, Gutiérrez-Salmeán G, Fanghaenel G et al. Once again, what's in a name? Redefining the concepts of the metabolic syndrome and obesity phenotypes. Part II. Rev Mex Cardiol. 2017; 28: 154-162.

3. Smith NK, Grueter BA. Hunger-driven adaptive prioritization of behavior. Hunger-driven adaptive prioritization of behavior. FEBS J. 2022; 289 (4): 922-936.

4. Yi CX, Tschop MH. Brain-gut-adipose-tissue communication pathways at a glance. Dis Model Mech. 2012; 5 (5): 583-587.

5. Münzberg H, Morrison CD. Structure, production and signaling of leptin. Metab.: Clin. Exp. 2015; 64: 13-23.

6. Jiang H, Ren F, Sun J et al. Molecular cloning and gene expression analysis of the leptin receptor in the Chinese mitten Crab Eriocheir sinensis. Plos One. 2010; 5: e11175.

7. Zandawala M, Gera J. Leptin- and cytokine-like unpaired signaling in Drosophila. Mol Cell Endocrinol. 2024; 584: 112165.

8. Davis K, Cheong MC, Park JS, You YJ. Appetite control in C elegans. In: Harris RBS, editor. Appetite and Food Intake: Central Control. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2017. Chapter 1.

9. Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015; 64: 24-34.

10. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: A review of its peripheral actions and interactions. Obes Relat Metab Disord. 2002; 26 (11): 1407-1433.

11. Licinio J, Negrao AB, Mantzoros C et al. Sex differences in circulating human leptin pulse amplitude: Clinical implications. J Clin Endocrinol Metab. 1998; 83: 4140-4147.

12. Ellis KJ, Nicolson M. Leptin levels and body fatness in children: effects of gender, ethnicity, and sexual development. Pediatr Res. 1997; 42: 484-488.

13. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care. 2010; 33: 1629-1634.

14. Morimoto Y, Conroy SM, Ollberding NJ et al. Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort. Int J Obes. 2014; 38: 1416-1422.

15. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: Implications for the control of regional fat distribution. Diabetes. 1997; 46: 342-347.

16. Skurk T, Van Harmelen V, Blum WF, Hauner H. Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2 dependent pathway. Obes Res. 2005; 13: 969-973.

17. Hsuchou H, Wang Y, Cornelissen-Guillaume GG et al. Diminished leptin signaling can alter circadian rhythm of metabolic activity and feeding. J Appl Physiol. 2013; 115: 995-1003.

18. Martins M do C, Lima Faleiro L, Fonseca A. Relationship between leptin and body mass and metabolic syndrome in an adult population. Rev Port Cardiol. 2012; 31: 711-709.

19. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996; 81: 3419-3423.

20. Kirel B, Tekin N, Tekin B, Kilic FS, Dogruel N, Aydogdu SD. Cord blood leptin levels: Relationship to body weight, body mass index, sex and insulin and cortisol levels of maternal-newborn pairs at delivery. JPEM. 2000; 13: 71-77.

21. Tung WK, Lin SJ, Hwang YS, Wu CM, Wang YH, Tsai WH. Association of cord plasma leptin with birth size in term newborns. Pediatr Neonatol. 2009; 50: 255-260.

22. Maffeis C, Moghetti P, Vettor R, Lombardi AM, Vecchini S, Tato L. Leptin concentration in newborns' cord blood: relationship to gender and growth-regulating hormones. Int J Obes. 1999; 23: 943-947.

23. Yalinbas EE, Binay C, Simsek E, Aksit MA. The role of umbilical Cord blood concentration of IGF-I, IGF-II, leptin, adiponectin, ghrelin, resistin, and visfatin in fetal growth. Am J Perinatol. 2019; 36: 600-608.

24. Laml T, Preyer O, Schulz-Lobmeyr I, Ruecklinger E, Hartmann BW, Wagenbichler P. Umbilical venous leptin concentration and gender in newborns. J Soc Gynecol Investig. 2001; 8: 94-97.

25. Tome MA, Lage M, Camiña JP, Garcia-Mayor RV, Dieguez C, Casanueva FF. Sex-based differences in serum leptin concentrations from umbilical cord blood at delivery. Eur J Endocrinol. 1997; 137: 655-658.

26. Yang SW, Kim SY. The relationship of the levels of leptin, insulin-like growth factor-I and insulin in cord blood with birth size, ponderal index, and gender difference. J Pediatr Endocrinol Metab. 2000; 13: 289-296.

27. Ertl T, Funke S, Sárkény I et al. Postnatal changes of leptin levels in full-term and preterm neonates: Their relation to intrauterine growth, gender and testosterone. Biol Neonate. 1999; 75: 167-176.

28. Kayemba-Kay's S, Geary MPP, Pringle J, Rodeck CH, Kingdom JCP, Hindmarsh PC. Gender, smoking during pregnancy and gestational age influence cord leptin concentrations in newborn infants. Eur J Endocrinol. 2008; 159: 217-224.

29. Sindiani AM, Obeidat R, Jbarah O, Hazaimeh E. Relationship between newborn leptin levels and selected growth parameters. J Int Med Res. 2019; 47: 2591-2597.

30. Hytinantti T, Koistinen HA, Koivisto VA, Karonen SL, Andersson S. Changes in leptin concentration during the early postnatal period: Adjustment to extrauterine life? Pediatr Res. 1999; 45: 197-201.

31. Collinson A, Moore S, O'Connell M, Charalambos C, Prentice A. Developmental changes in leptin as a measure of energy status in human infants in a natural ecologic setting. Am J Clin Nutr. 2005; 81: 488-494.

32. Lonnerdal B, Havel PJ. Serum leptin concentrations in infants: effects of diet, sex, and adiposity. Am J Clin Nutr. 2000; 72: 484-489.

33. Savino F, Rossi L, Benetti S, Petrucci E, Sorrenti M, Silvestro L. Serum reference values for leptin in healthy infants. PLoS One. 2014; 9: 94-97.

34. Erhardt E, Foraita R, Pigeot I et al. Reference values for leptin and adiponectin in children below the age of 10 based on the IDEFICS cohort. Int J Obes. 2014; 38: S32-S38.

35. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage 1. J Clin Endocrinol Metab. 1997; 82: 2849-2855.

36. Lausten-Thomsen U, Lund MAV, Frithioff-Bojsoe C et al. Reference values for leptin/adiponectin ratio in healthy children and adolescents. Clin Chim Acta. 2019; 493: 123-128.

37. Wang T, Morioka I, Gowa Y et al. Serum leptin levels in healthy adolescents: effects of gender and growth. Environ Health Prev Med. 2004; 9: 41-46.

38. De Dios O, Herrero L, Vales-Villamarín C, Mahíllo-Fernández I, Soriano-Guillén L, Garcés C. Sex steroid hormones, leptin, and high-sensitivity C-reactive protein levels in adolescents. Andrology. 2021; 9: 829-836.

39. Al-Harithy RN. Relationship of leptin concentration to gender, body mass index and age in saudi adults. Saudi Med J. 2004; 25: 1086-1090.

40. Rosenbaum M, Nicolson M, Hirsch J et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996; 81: 3424-3427.

41. Stunner AE. Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans. Obes Res. 1998; 6: 128-133.

42. Carraro R, Ruiz-Torres A. Relationship of serum leptin concentration with age, gender, and biomedical parameters in healthy, non-obese subjects. Arch Gerontol Geriatr. 2006; 43: 301-312.

43. Hickey MS, Israel RG, Gardiner SN et al. Gender differences in serum leptin levels in humans. Biochem Mol Med. 1996; 59: 1-6.

44. Hellstrom L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P. Mechanisms behind gender differences in circulating leptin levels. J Intern Med. 2000; 247: 457-462.

45. Isidori AM, Strollo F, Moré M et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab. 2000; 85: 1954-1962.

46. Wong SL, DePaoli AM, Lee JH, Mantzoros CS. Leptin hormonal kinetics in the fed state: effects of adiposity, age, and gender on endogenous leptin production and clearance rates. J Clin Endocrinol Metab. 2004; 89 (6): 2672-2677.

47. Moller N, O'Brien P, Nair KS. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocrinol Metab. 1998; 83: 931-934.

48. Koistinen HA, Koivisto VA, Karonen SL, Ronnemaa T, Tilvis RS. Serum leptin and longevity. Aging Clin Exp Res. 1998;10: 449-454.

49. Dubuc GR, Phinney SD, Stern JS, Havel PJ. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism. 1998; 47: 429-434.

50. Hadji P, Hars O, Bock K et al. The influence of menopause and body mass index on serum leptin concentrations. Eur J Endocrinol. 2000; 143: 55-60.

51. Douchi T, Iwamoto I, Yoshimitsu N, Kosha S, Nagata Y. Leptin production in pre- and postmenopausal women. Maturitas. 2002; 42: 219-223.

52. Iwamoto I, Douchi T, Kosha S, Murakami M, Fujino T, Nagata Y. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand. 2000; 79: 1060-1064.

53. Rolland YM, Perry HM, Patrick P, Banks WA, Morley JE. Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers-a cross-sectional study. Metabolism. 2006; 55: 1630-1636.

54. Lee SW, Jo HH, Kim MR, You YO, Kim JH. Association between metabolic syndrome and serum leptin levels in postmenopausal women. J Obstet Gynaecol (Lahore). 2012; 32: 73-77.

55. Mahabir S, Baer D, Johnson LL et al. Body Mass Index, percent body fat, and regional body fat distribution in relation to leptin concentrations in healthy, non-smoking postmenopausal women in a feeding study. Nutr J. 2007; 6: 3.

56. Mishra S, Harris TB, Hsueh WC et al. The association of serum leptin with mortality in older adults. PLoS One. 2015;10: e0140763.

57. Sherk VD, Malone SP, Bemben MG, Knehans AW, Palmer IJ, Bemben DA. Leptin, fat mass, and bone mineral density in healthy pre- and postmenopausal women. J Clin Densitom. 2011; 14: 321-325.

58. Baumgartner RN, Waters DL, Morley JE, Patrick P, Montoya GD, Garry PJ. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism. 1999; 48: 378-384.

59. Blain H, Vuillemin A, Guillemin F et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2002; 87: 1030-1035.

60. Al Maskari MY, Alnaqdy AA. Correlation between serum leptin levels, body mass index and obesity in Omanis. Sultan Qaboos Univ Med J. 2006; 6: 27-31.

61. Adeyemi E, Abdulle A. A comparison of plasma leptin levels in obese and lean individuals in the United Arab Emirates. Nutr. Res. 2000;20: 157-166.

62. Nuttall FQ. Body mass index: obesity, BMI, and health: A critical review, Nutrition Today. 2015. 50: 117-128.

63. Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016. 118: 1786-807.

64. Fanghanel-Salmón G, Gutiérrez-Salmeán G, Samaniego V et al. Obesity phenotypes in urban middle-class cohorts; the PRIT-Lindavista merging evidence in Mexico: The OPUS PRIME study. Nutr Hosp. 2015; 32: 182-188.

65. Bremer AA, Devaraj S, Afify A, Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011; 96: 10-24.

66. Jamar G, Caranti DA, de Cassia CH, Masquio DCL, Bandoni DH, Pisani LP. Leptin as a cardiovascular risk marker in metabolically healthy obese: Hyperleptinemia in metabolically healthy obese. Appetite. 2017; 108: 477-482.

67. Farb MG, Bigornia S, Mott M et al. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol. 2011;58: 232-237.

68. Aisike G, Kuerbanjiang M, Muheyati D, Zaibibuli K, Lv MX, Han J. Correlation analysis of obesity phenotypes with leptin and adiponectin. Sci Rep. 2023; 13: 17718.

69. Jamroz-Wi?niewska A, Gertler A, Solomon G, Wood ME, Whiteman M, Beltowski J. Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: Role of nitric oxide and hydrogen sulfide. PLoS One. 2014;9: e86744.

70. Quehenberger P, Exner M, Sunder-Plassmann R et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002; 90: 711-718.

71. Vilariño-García T, Polonio-González ML, Pérez-Pérez A et al. Role of leptin in obesity, cardiovascular disease, and type 2 diabetes. Int J Mol Sci. 2024; 25: 2338

72. Garonna E, Botham KM, Birdsey GM, Randi AM, Gonzalez-Perez RR, Wheeler-Jones CPD. Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells. PLoS One. 2011; 6: e0223400.

73. Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Leptin resistance: underlying mechanisms and diagnosis. Vol. 12, Diabetes, Metabolic Syndrome and Obesity. 2019.

74. Noblet JN, Goodwill AG, Sassoon DJ, Kiel AM, Tune JD. Leptin augments coronary vasoconstriction and smooth muscle proliferation via a Rho-kinase-dependent pathway. Basic Res Cardiol. 2016; 111: 191-198.

75. Buis DTP, Christen T, Smit RAJ, de Mutsert R, Jukema JW, Cannegieter SC, et al. The association between leptin concentration and blood coagulation: Results from the NEO study. Thromb Res. 2020; 188: 44-48.

76. Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via its long receptor form. Diabetes. 1999; 48: 426-429.

77. Chavez RJ, Haney RM, Cuadra RH et al. Upregulation of thrombospondin-1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathways. Am J Physiol Cell Physiol. 2012; 303: 179-191.

78. Bouloumié A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. The FASEB Journal. 1999;13: 1231-1238.

79. El-Mikkawy DME, EL-Sadek MA, EL-Badawy MA, Samaha D. Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity. Egypt Rheumatol Rehabil. 2020; 47: 1-7.

80. Canavan B, Salem RO, Schurgin S et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab. 2005;90: 5779-5785.

81. Maachi M, Piéroni L, Bruckert E et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese women. Int J Obes. 2004; 28: 993-997.

82. Beltowski J, Wójcicka G, Marciniak A, Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci. 2004; 74: 2987-3000.

83. Zhang Z, Wang F, Wang BJ et al. Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin. J Mol Endocrinol. 2014; 53: 145-154.

84. Martínez-Martínez E, Miana M, Jurado-López R et al. The potential role of leptin in the vascular remodeling associated with obesity. Int J Obes. 2014; 38: 1565-1572.

85. Madani S, De Girolamo S, Muñoz DM, Li RK, Sweeney G. Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res. 2006; 69: 716-725.

86. Kang KW, Ok M, Lee SK. Leptin as a key between obesity and cardiovascular disease. Obes Metab Syndr. 2020; 29: 248-259.

87. Pieterse C, Schutte R, Schutte AE. Leptin links with plasminogen activator inhibitor-1 in human obesity: The SABPA study. Hypertens Res. 2015; 38: 507-512.

88. Poetsch MS, Strano A, Guan K. Role of Leptin in Cardiovascular Diseases. Front Endocrinol . 2020; 11: 354.

89. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: Does leptin have a role? J Am Coll Cardiol. 2011; 58: 1870-1877.

90. Bobbert P, Jenke A, Bobbert T et al. High leptin and resistin expression in chronic heart failure: Adverse outcome in patients with dilated and inflammatory cardiomyopathy. Eur J Heart Fail. 2012; 14: 1265-1275.

91. Smith CCT, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol. 2006;149: 5-13.

92. Hill JW. Gene Expression and the Control of Food Intake by Hypothalamic POMC/CART Neurons. Open Neuroendocrinol J. 2010; 3: 21-27.

93. Picó C, Palou M, Pomar CA, Rodríguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022. 23: 13-30.

94. Julliard AK, Chaput MA, Apelbaum A, Aimé P, Mahfouz M, Duchamp-Viret P. Changes in rat olfactory detection performance induced by orexin and leptin mimicking fasting and satiation. Behav Brain Res. 2007; 183: 123-129.

95. Hommel JD, Trinko R, Sears RM et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006; 51: 801-810.

96. Fulton S, Pissios P, Manchon RP et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006; 51: 811-822.

97. Thanos PK, Robison LS, Robinson JK, Michaelides M, Wang GJ, Volkow ND. Obese rats with deficient leptin signaling exhibit heightened sensitivity to olfactory food cues. Synapse. 2013; 67: 171-178.

98. Shi Z, Pelletier NE, Wong J et al. Leptin increases sympathetic nerve activity via induction of its own receptor in the paraventricular nucleus. Elife. 2020; 9: e55357.

99. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997; 100: 270-278.

100. Shanley LJ, Irving AJ, Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci. 2001; 21: RC186.

101. Komori T, Morikawa Y, Nanjo K, Senba E. Induction of brain-derived neurotrophic factor by leptin in the ventromedial hypothalamus. Neuroscience. 2006; 139: 1107-1115.

102. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: Leptin inhibits cortisol release directly. Diabetes. 1997; 46: 1235-1238.

103. Guo F, Bakal K, Minokoshi Y, Hollenberg AN. Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology. 2004; 145: 2221-2227.

104. Hausman GJ, Barb CR, Lents CA. Leptin and reproductive function. Biochimie. 2012; 94: 2075-2081.

105. Tannenbaum GS, Gurd W, Lapointe M. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology. 1998; 139: 3871-3875.

106. Koltes DA, Spurlock ME, Spurlock DM. Adipose triglyceride lipase protein abundance and translocation to the lipid droplet increase during leptin-induced lipolysis in bovine adipocytes. Domest Anim Endocrinol. 2017; 61: 62-76.

107. Frühbeck G, Aguado M, Gómez-Ambrosi J, Martínez JA. Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Res Commun. 1998; 250: 99-102.

108. Wang MY, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem. 1999; 274 (25): 17541-17544.

109. Shen J, Tanida M, Niijima A, Nagai K. In vivo effects of leptin on autonomic nerve activity and lipolysis in rats. Neurosci Lett. 2007; 416: 193-197.

110. Kakuma T, Wang ZW, Wentong PAN, Unger RH, Zhou YT. Role of leptin in peroxisome proliferator-activated receptor gamma coactivator-1 expression. Endocrinology. 2000; 141: 4576-4582.

111. Minokoshi Y, Kim YB, Peroni OD et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002; 415: 339-343.

112. Wein S, Ukropec J, Gasperíková D, Klimes I, Seboková E. Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver. Exp Clin Endocrinol Diabetes. 2007; 115: 244-251.

113. Quaye E, Chacko S, Startzell M, Brown RJ. Leptin decreases gluconeogenesis and gluconeogenic substrate availability in patients with lipodystrophy. J Clin Endocrinol Metab. 2024; 109: e209-e215.

114. Gamarra JR, Haeusler RA. Hepatocentric leptin signaling modulates gluconeogenesis via MKP-3. Cell Mol Gastroenterol Hepatol. 2022; 14: 1166-1167.

115. Bai Z, Ye Y, Ye X et al. Leptin promotes glycolytic metabolism to induce dendritic cells activation via STAT3-HK2 pathway. Immunol Lett. 2021; 239: 88-95.

116. Douros JD, Baltzegar DA, Reading BJ et al. Leptin stimulates cellular glycolysis through a STAT3 dependent mechanism in Tilapia. Front Endocrinol (Lausanne). 2018; 9: 465.

117. Yadav NK, Arjuman A, Chandra NC. Role of leptin on the expression of low density lipoprotein receptor. Indian J Med Res. 2014; 140: 524-530.

118. Kosztáczky B, Fóris G, Paragh G et al. Leptin stimulates endogenous cholesterol synthesis in human monocytes: New role of an old player in atherosclerotic plaque formation. Leptin-induced increase in cholesterol synthesis. Int J Biochem Cell Biol. 2007; 39: 1637-1645.

119. Kulkarni RN, Wang ZL, Wang RM et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest. 1997; 100: 2729-2736.

120. Boucsein A, Kamstra K, Tups A. Central signalling cross-talk between insulin and leptin in glucose and energy homeostasis. J Neuroendocrinol. 2021; 33: e12944.

121. Rossetti L, Massillon D, Barzilai N et al. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem. 1997; 272: 27758-27763.

122. German JP, Thaler JP, Wisse BE et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology. 2011; 152: 394-404.

123. Ceddia RB, William WN, Lima FB, Flandin P, Curi R, Giacobino JP. Leptin stimulates uncoupling protein-2 mRNA expression and Krebs cycle activity and inhibits lipid synthesis in isolated rat white adipocytes. Eur J Biochem. 2000; 267: 1432-1327.

124. Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta. 2014; 1842: 414-423.

125. Belouzard S, Delcroix D, Rouillé Y. Low levels of expression of leptin receptor at the cell surface result from constitutive endocytosis and intracellular retention in the biosynthetic pathway. J Biol Chem. 2004; 279: 28499-28508.

126. Wauman J, Zabeau L, Tavernier J. The leptin receptor complex: Heavier than expected? Front Endocrinol (Lausanne). 2017; 8: 30.

127. Mitchell SE, Nogueiras R, Morris A et al. Leptin receptor gene expression and number in the brain are regulated by leptin level and nutritional status. J Physiol. 2009; 587: 3573-3585.

128. Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995; 83: 1263-1271.

129. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun. 2001; 283: 982-988.

130. Wauman J, De Ceuninck L, Vanderroost N, Lievens S, Tavernier J. RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding. J Cell Sci. 2011; 124: 921-932.

131. Kielar D, Clark JSC, Ciechanowicz A, Kurzawski G, Sulikowski T, Naruszewicz M. Leptin receptor isoforms expressed in human adipose tissue. Metabolism. 1998; 47: 844-847.

132. Saxton RA, Caveney NA, Moya-Garzon MD et al. Structural insights into the mechanism of leptin receptor activation. Nat Commun. 2023; 14: 1797.

133. Fei H, Okano HJ, Li C et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA. 1997; 94: 7001-7005.

134. Holtkamp K, Hebebrand J, Mika C, Heer M, Heussen N, Herpertz-Dahlmann B. High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa. Psychoneuroendocrinology. 2004; 29: 791-797.

135. Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res. 2003; 11: 760-768.

136. Herrick JE, Panza GS, Gollie JM. Leptin, leptin soluble receptor, and the free leptin index following a diet and physical activity lifestyle Intervention in obese males and females. J Obes. 2016; 8375828.

137. Bochukova EG, Huang N, Keogh J et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature. 2010; 463: 666-670.

138. Saeed S, Bonnefond A, Manzoor J et al. Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity. 2015; 23: 1687-1695.

139. Huvenne H, Dubern B, Clément K, Poitou C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obese Facts. 2016; 9: 158-173.

140. Caro JF, Kolaczynski JW, Nyce MR et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996; 348: 159-161.

141. Banks WA. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des. 2001; 7 (2): 125-133.

142. Van Heek M, Compton DS, France CF. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest. 1997; 99 (3): 385-390.

143. Lanaspa MA, Kuwabara M, Andres-Hernando A et al. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc Natl Acad Sci USA. 2018; 115: E9509.

144. Banks WA, Coon AB, Robinson SM et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004; 53: 1253-1260.

145. Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez F et al. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med. 2008; 5: 418-425.

146. Hribal M, Fiorentino T, Sesti G. Role of C reactive protein (CRP) in leptin resistance. Curr Pharm Des. 2014; 20: 609-615.